Commission on the Federal Drug Approval Process : final report

LDR 01740cam a2200385 a 4500
001 102286151
003 MiAaHDL
005 20180416000000.0
006 m d
007 cr bn ---auaua
008 830629s1982 dcu b f000 0 eng d
010 ‡a 83602254
035 ‡asdr-srlf3338597
035 ‡asdr-ucr.b19302460
035 ‡907-AMB-0595
035 ‡a(OCoLC)9078932
040 ‡aDGPO/DLC ‡cDLC ‡dm/c
043 ‡an-us---
050 0 ‡aRS189 ‡b.U47 1982
082 0 ‡a363.1/9464$219
086 0 ‡aY 4.Sci 2:97/CC
110 1 ‡aUnited States. ‡bCommission on the Federal Drug Approval Process.
245 1 0 ‡aCommission on the Federal Drug Approval Process : ‡bfinal report / ‡cprepared by the Subcommittee on Natural Resources, Agriculture Research and Environment and the Subcommittee on Investigations and Oversight ; transmitted to the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, second session.
260 ‡aWashington : ‡bU.S. G.P.O., ‡c1982.
300 ‡axvii, 106 p. ; ‡c24 cm.
500 ‡aItem 1025-A-1, 1025-A-2 (microfiche)
500 ‡a"Serial CC."
500 ‡a"October 1982."
500 ‡aAt head of title: Committee print.
504 ‡aIncludes bibliographical references.
538 ‡aMode of access: Internet.
610 1 0 ‡aUnited States. ‡bFood and Drug Administration.
650 0 ‡aPharmaceutical policy ‡zUnited States.
650 0 ‡aDrugs ‡zUnited States ‡xTesting.
710 1 ‡aUnited States. ‡bCongress. ‡bHouse. ‡bCommittee on Science and Technology. ‡bSubcommittee on Investigations and Oversight.
710 1 ‡aUnited States. ‡bCongress. ‡bHouse. ‡bCommittee on Science and Technology. ‡bSubcommittee on Natural Resources, Agriculture Research, and Environment.
CID ‡a102286151
DAT 0 ‡a20170831153857.0 ‡b20180416000000.0
DAT 1 ‡a20180417090546.0 ‡b2024-04-19T18:05:53Z
DAT 2 ‡a2024-04-19T17:30:01Z
CAT ‡aSDR-SRLF ‡dEX LIBRIS - VOYAGER ‡lprepare.pl-004-007
FMT ‡aBK
HOL ‡0sdr-srlf3338597 ‡auc1 ‡bSDR ‡cSRLF ‡puc1.aa0000504266 ‡sUC ‡13338597
974 ‡bUC ‡cSRLF ‡d20240419 ‡sgoogle ‡uuc1.aa0000504266 ‡y1982 ‡rpd ‡qbib ‡tUS fed doc
974 ‡bUC ‡cUCR ‡d20240427 ‡sgoogle ‡uuc1.31210018782613 ‡y1982 ‡rpd ‡qbib ‡tUS fed doc